U.S. Dental Membrane and Bone Graft Substitutes Market to Surpass US$ 333.6 Million by 2028 - Coherent Market Insights

U.S. Dental Membrane and Bone Graft Substitutes Market, by Product Type (Dental Membrane (Resorbable Membranes and Non-resorbable Membranes) and Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft, and Synthetic Bone Graft Substitute)), by Material (Collagen, Hydrogel, Hydroxyapatite (HA), Tricalcium Phosphate (TCP), Polytetrafluoroethylene, Human Cells Source, and Others), by Application (Socket Preservation, Ridge Augmentation, Sinus Lifts, Guided Bone Regeneration (GBR), and Guided Tissue Regeneration (GTR)), and by End User (Hospitals, Dental Clinics, and Others), is estimated to be valued at US$ 171.9 Mn in 2021 and is expected to exhibit a CAGR of 9.9% during the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.

Manufacturers are focused on expanding their position in the dental membrane and bone graft substitute market through product developments, in order to meet escalating demand for treatment of oral health issues. For instance, in October 2017, LifeNet Health launched PliaFX Strip allograft for dental and bone healing. The product provides higher efficiency. PliaFX, composed of cortical bone fibers, is created using an exclusive, patented processing technology. Furthermore, increasing regulatory approvals for synthetic bone graft substitute products is expected to boost growth of the U.S. dental membrane and bone graft substitutes market over the forecast period. For instance, in 2017, Anika Therapeutics, Inc. received 510(k) clearance from the U.S. Food and Drug Administration for their hyaluronic acid bone void filler and is specifically used for correcting the defects of skeletal system. The bone void filler, composed of a synthetic and bone graft substitute made of biocompatible material, is placed into a void, which solidifies at body temperature.

U.S. Dental Membrane and Bone Graft Substitutes Market– Impact of Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 a pandemic on March 11, 2020. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 43 million cases and 0.69 million deaths due to coronavirus disease (COVID-19) were reported up till September 23, 2021, across the U.S.

Furthermore, dental surgeons are at the highest risk of contracting and transmitting the coronavirus (COVID-19). Moreover, patient’s mindset and fear of getting infected has restricted the number of visits to dental clinics. Hence, the declining patient visits for dental procedures are hampering demand for dental equipment, which has negatively impacted sales revenue of dental equipment manufacturers.

Browse 20 Market Data Tables and 25 Figures spread through 222 Pages and in-depth TOC on “U.S. Dental Membrane and Bone Graft Substitutes Market”-  Forecast to 2028, U.S. Dental Membrane and Bone Graft Substitutes Market, by Product Type (Dental Membrane (Resorbable Membranes and Non-resorbable Membranes) and Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft, and Synthetic Bone Graft Substitute)), by Material (Collagen, Hydrogel, Hydroxyapatite (HA), Tricalcium Phosphate (TCP), Polytetrafluoroethylene, Human Cells Source, and Others), by Application (Socket Preservation, Ridge Augmentation, Sinus Lifts, Guided Bone Regeneration (GBR), and Guided Tissue Regeneration (GTR)), and by End User (Hospitals, Dental Clinics, and Others)

To know the latest trends and insights prevalent in the U.S. Dental Membrane and Bone Graft Substitutes Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/us-dental-membrane-and-bone-graft-substitutes-market-4749

Moreover, the increasing launches of synthetic bone graft substitutes by the market players is expected to drive growth of U.S. dental membrane and bone graft substitutes market over the forecast period. For instance, in 2020, OrthoPediatrics Corp., a company focusing exclusively on the field of pediatric orthopedics, launched QuickPack, a fully synthetic bone graft substitute with a high viscosity, calcium phosphate cement that mimics the mineral phase of natural bone.

Key Takeaways of the U.S. Dental Membrane and Bone Graft Substitutes Market:

• The U.S. dental membrane and bone graft substitutes market is expected to exhibit a CAGR of 9.9% during the forecast period, owing to rising government support for growth of the healthcare sector is expected to support growth of the market during the forecast period. For instance, in September 2021, the U.S. Department of Veterans Affairs (VA) launched a new initiative in collaboration with community dental care providers to improve dental care access for veterans enrolled in VA health care who are currently ineligible for VA dental services.
• Based on product type, bone graft substitutes segment is estimated to grow with the fastest CAGR in the U.S. dental membrane and bone graft substitutes market over the forecast period, owing to increasing product launches of allograft by the key players. For instance, in July 2020, Spine Wave Inc. announced the successful launch of tempest allograft bone matrix. The tempest allograft bone matrix is composed of cancellous and partially demineralized cortical bone.
• Among material, collagen segment is estimated to grow with the fastest CAGR over the forecast period in the U.S. dental membrane and bone graft substitutes market. Collagen is used for manufacturing of restorable dental membranes. The major advantages associated with the use of collagen include ease of handling, strength, and higher resorption time.
• On the basis of application, ridge augmentation segment is estimated to grow with the fastest CAGR over the forecast period. Ridge augmentation is a common dental procedure often performed following a tooth extraction. This procedure helps recreate the natural shape of the gums and jaw that may have been lost due to bone loss from a tooth extraction, or for another reason.
• Among end user, dental clinics is expected to exhibit highest CAGR in the S. dental membrane and bone graft substitutes market through the forecast period. For instance, according to article published in National Center for Biotechnology Information, approximately 85% of dentists in the U.S. opt for private practice suggesting the increase in number of dental clinics in the near future.
• Major players operating in the U.S. dental membrane and bone graft substitutes market include Institut Straumann AG, Nobel Biocare Services AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., Osteogenics Biomedical., Medtronic, and OUSIA.